Potential implications of GRP58 expression and susceptibility of cervical cancer to cisplatin and thymoquinone-based therapy

References

• JuradoMMartinez-MongeRGarcia-FoncillasJPilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery ± intraoperative electron beam radiotherapy in locally advanced cervical cancerGynecol Oncol1999741303710385548
   PubMed Web of Science ®Google Scholar
• BaeJHLeeSJLeeANeoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancerGynecol Oncol2008111344444818829085
   PubMed Web of Science ®Google Scholar
• PignataSSilvestroGFerrariEPhase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervixJ Clin Oncol199917375676010071263
   PubMed Web of Science ®Google Scholar
• RosePGSillMWMcMeekinDSA phase I study of concurrent weekly topotecan and cisplatin chemotherapy with whole pelvic radiation therapy in locally advanced cervical cancer: a gynecologic oncology group studyGynecol Oncol2012125115816222198338
   PubMed Web of Science ®Google Scholar
• ManciNMarchettiCDi TucciCA prospective phase II study of topotecan (Hycamtin(R)) and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancerGynecol Oncol2011122228529021555147
   PubMed Web of Science ®Google Scholar
• MooreDHBlessingJAMcQuellonRPPhase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group studyJ Clin Oncol200422153113311915284262
   PubMed Web of Science ®Google Scholar
• Dueňas-GonzálezAOrlandoMZhouYQuinlivanMBarracloughHEfficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chemoradiotherapy plus adjuvant gemcitabine and cisplatin: prognostic and predictive factors and the impact of disease stage on outcomes from a prospective randomized phase III trialGynecol Oncol2012126333434022691757
   PubMed Web of Science ®Google Scholar
• SugiyamaTYakushijiMNodaKPhase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancerOncology2000581313710644938
   PubMed Web of Science ®Google Scholar
• OikeTOhnoTNodaSEComparison of hematological toxicities between innovator and generic cisplatin formulations in cervical cancer patients treated with concurrent chemoradiotherapyJ Radiat Res20121414
   Google Scholar
• LongHJBundyBNGrendysECRandomized Phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group StudyJ Clin Oncol200523214626463315911865
   PubMed Web of Science ®Google Scholar
• KongTWChangSJPaekJComparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancerJ Gynecol Oncol201223423524123094126
   PubMed Web of Science ®Google Scholar
• AttoubSSperandioORazaHThymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivoFundam Clin Pharmacol201327555756922788741
   PubMed Web of Science ®Google Scholar
• WooCCLooSYGeeVAnticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-gamma pathwayBiochem Pharmacol201182546447521679698
   PubMed Web of Science ®Google Scholar
• RaghunandhakumarSParamasivamASenthilrajaSThymoquinone inhibits cell proliferation through regulation of G1/S phase cell cycle transition in N-nitrosodiethylamine-induced experimental rat hepatocellular carcinomaToxicol Lett20133130129001293
   Google Scholar
• ParamasivamASambanthamSShabnamJAnti-cancer effects of thymoquinone in mouse neuroblastoma (Neuro-2a) cells through caspase-3 activation with down-regulation of XIAPToxicol Lett2012213215115922732633
   PubMed Web of Science ®Google Scholar
• AbdelfadilEChengYHBauDTThymoquinone induces apoptosis in oral cancer cells through p38beta inhibitionAm J Chin Med201341368369623711149
   PubMed Web of Science ®Google Scholar
• LiaoCJWuTIHuangYHGlucose-regulated protein 58 modulates cell invasiveness and serves as a prognostic marker for cervical cancerCancer Sci2011102122255226321917082
   PubMed Web of Science ®Google Scholar
• ChayDChoHLimBJER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139Int J Oncol201037239941220596667
   PubMed Web of Science ®Google Scholar
• LeysCMNomuraSLaFleurBJExpression and prognostic significance of prothymosin-alpha and ERp57 in human gastric cancerSurgery20071411415017188166
   PubMed Web of Science ®Google Scholar
• AyshamgulHMaHIlyarSZhangLWAbuliziAAssociation of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancerChin Med J (Engl)2011124334134621362330
   PubMed Web of Science ®Google Scholar
• MehtaAMJordanovaESKenterGGFerroneSFleurenGJAssociation of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinomaCancer Immunol Immunother200857219720617622526
   PubMed Web of Science ®Google Scholar
• TanakaTKuramitsuYFujimotoMNaitoSOkaMNakamuraKDownregulation of two isoforms of ubiquitin carboxyl-terminal hydrolase isozyme L1 correlates with high metastatic potentials of human SN12C renal cell carcinoma cell clonesElectrophoresis200829122651265918494032
   PubMed Web of Science ®Google Scholar
• HetzCRusselakis-CarneiroMWalchliSThe disulfide isomerase Grp58 is a protective factor against prion neurotoxicityJ Neurosci200525112793280215772339
   PubMed Web of Science ®Google Scholar
• CorazzariMLovatPEArmstrongJLTargeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57Br J Cancer20079671062107117353921
   PubMed Web of Science ®Google Scholar
• LwinZMYipGWChewFTBayBHDownregulation of ER60 protease inhibits cellular proliferation by inducing G1/S arrest in breast cancer cells in vitroAnat Rec (Hoboken)2012295341041622266712
   PubMedGoogle Scholar
• ChungHChoHPerryCDownregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancerBiomarkers201318757357923957851
   PubMed Web of Science ®Google Scholar
• JessopCETavenderTJWatkinsRHChambersJEBulleidNJSubstrate specificity of the oxidoreductase ERp57 is determined primarily by its interaction with calnexin and calreticulinJ Biol Chem200928442194220219054761
   PubMed Web of Science ®Google Scholar
• MayerMFreySKoivunenPMyllyharjuJBuchnerJInfluence of the oxidoreductase ER57 on the folding of an antibody fab fragmentJ Mol Biol200434141077108415328618
   PubMed Web of Science ®Google Scholar
• ChichiarelliSFerraroAAltieriFThe stress protein ERp57/GRP58 binds specific DNA sequences in HeLa cellsJ Cell Physiol2007210234335117061245
   PubMed Web of Science ®Google Scholar
• MandicAHanssonJLinderSShoshanMCCisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signalingJ Biol Chem2003278119100910612509415
   PubMed Web of Science ®Google Scholar
• MosmannTRapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assaysJ Immunol Methods1983651–255636606682
   PubMed Web of Science ®Google Scholar
• NgWKYazanLSIsmailMThymoquinone from Nigella sativa was more potent than cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 proteinToxicol In Vitro20112571392139821609759
   PubMed Web of Science ®Google Scholar
• RahmanHSRasedeeAAbdulABZerumbone-loaded nanostructured lipid carrier induces G2/M cell cycle arrest and apoptosis via mitochondrial pathway in a human lymphoblastic leukemia cell lineInt J Nanomedicine2014952753824549090
   PubMed Web of Science ®Google Scholar
• BradfordMMA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnal Biochem197672248254942051
   PubMed Web of Science ®Google Scholar
• NakataniKNakamuraMUzawaKEstablishment and gene analysis of a cisplatin-resistant cell line, Sa-3R, derived from oral squamous cell carcinomaOncol Rep200513470971415756446
   PubMed Web of Science ®Google Scholar
• BernardiniMLeeCHBeheshtiBHigh-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancerNeoplasia20057660361316036111
   PubMed Web of Science ®Google Scholar
• ColingDEDingDYoungRProteomic analysis of cisplatin-induced cochlear damage: methods and early changes in protein expressionHear Res20072261–214015617321087
   PubMed Web of Science ®Google Scholar
• MeijerTWSchuurbiersOCKaandersJHDifferences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4Lung Cancer201276331632322153830
   PubMed Web of Science ®Google Scholar
• CliffordGMRanaRKFranceschiSSmithJSGoughGPimentaJMHuman papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancerCancer Epidemiol Biomarkers Prev20051451157116415894666
   PubMed Web of Science ®Google Scholar
• SchwarzEFreeseUKGissmannLStructure and transcription of human papillomavirus sequences in cervical carcinoma cellsNature198531460061111142983228
   PubMed Web of Science ®Google Scholar
• MeissnerJDNucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell linesJ Gen Virol199980Pt 71725173310423141
   PubMed Web of Science ®Google Scholar
• BakerCCPhelpsWCLindgrenVBraunMJGondaMAHowleyPMStructural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell linesJ Virol19876149629713029430
   PubMed Web of Science ®Google Scholar
• BrimerNVande PolSBPapillomavirus E6 PDZ interactions can be replaced by repression of p53 to promote episomal human papillomavirus genome maintenanceJ Virol20148853027303024352452
   PubMed Web of Science ®Google Scholar
• ZhangBChenWRomanAThe E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradationProc Natl Acad Sci U S A2006103243744216381817
   PubMed Web of Science ®Google Scholar
• LongworthMSLaiminsLAPathogenesis of human papillomaviruses in differentiating epitheliaMicrobiol Mol Biol Rev200468236237215187189
   PubMed Web of Science ®Google Scholar
• SuPFWuFYDifferential suppression of the tumorigenicity of HeLa and SiHa cells by adeno-associated virusBr J Cancer19967312153315378664125
   PubMed Web of Science ®Google Scholar
• CourteteJSiblerAPZeder-LutzGSuppression of cervical carcinoma cell growth by intracytoplasmic codelivery of anti-oncoprotein E6 antibody and small interfering RNAMol Cancer Ther2007661728173517575104
   PubMed Web of Science ®Google Scholar
• XuDPerezRERezaiekhalighMHBourdiMTruogWEKnockdown of ERp57 increases BiP/GRP78 induction and protects against hyperoxia and tunicamycin-induced apoptosisAm J Physiol Lung Cell Mol Physiol20092971L44L5119411306
   PubMed Web of Science ®Google Scholar
• UranoFWangXBertolottiACoupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1Science2000287545366466610650002
   PubMed Web of Science ®Google Scholar
• LiuFTNewlandACJiaLBax conformational change is a crucial step for PUMA-mediated apoptosis in human leukemiaBiochem Biophys Res Commun2003310395696214550297
   PubMed Web of Science ®Google Scholar
• NakanoKVousdenKHPUMA, a novel proapoptotic gene, is induced by p53Mol Cell20017368369411463392
   PubMed Web of Science ®Google Scholar
• GuoGGPatelKKumarVAssociation of the chaperone glucose-regulated protein 58 (GRP58/ER-60/ERp57) with Stat3 in cytosol and plasma membrane complexesJ Interferon Cytokine Res200222555556312060494
   PubMed Web of Science ®Google Scholar
• Ramirez-RangelIBracho-ValdesIVazquez-MaciasACarretero-OrtegaJReyes-CruzGVazquez-PradoJRegulation of mTORC1 complex assembly and signaling by GRp58/ERp57Mol Cell Biol20113181657167121321085
   PubMed Web of Science ®Google Scholar
• SerraVMarkmanBScaltritiMNVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutationsCancer Res200868198022803018829560
   PubMed Web of Science ®Google Scholar
• Catlett-FalconeRLandowskiTHOshiroMMConstitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cellsImmunity199910110511510023775
   PubMed Web of Science ®Google Scholar
• ZouCGCaoXZZhaoYSThe molecular mechanism of endoplasmic reticulum stress-induced apoptosis in PC-12 neuronal cells: the protective effect of insulin-like growth factor IEndocrinology2009150127728518801901
   PubMed Web of Science ®Google Scholar
• LiFRajendranPSethiGThymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathwayBr J Pharmacol2010161354155420880395
   PubMed Web of Science ®Google Scholar
• SethiGAhnKSAggarwalBBTargeting nuclear factor-κB activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosisMol Cancer Res2008661059107018567808
   PubMed Web of Science ®Google Scholar
• SakalarCYurukMKayaTAytekinMKukSCanatanHPronounced transcriptional regulation of apoptotic and TNF-NF-kappa-B signaling genes during the course of thymoquinone mediated apoptosis in HeLa cellsMol Cell Biochem20131414
   Google Scholar
• WadaTPenningerJMMitogen-activated protein kinases in apoptosis regulationOncogene200423162838284915077147
   PubMed Web of Science ®Google Scholar
• FengRZhaiWLYangHYJinHZhangQXInduction of ER stress protects gastric cancer cells against apoptosis induced by cisplatin and doxorubicin through activation of p38 MAPKBiochem Biophys Res Commun2011406229930421320468
   PubMed Web of Science ®Google Scholar